200 related articles for article (PubMed ID: 30958891)
1. Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction.
Xu Z; Zou C; Yu W; Xu S; Huang L; Khan Z; Wang J; Liang G; Wang Y
Br J Pharmacol; 2019 Jul; 176(14):2627-2641. PubMed ID: 30958891
[TBL] [Abstract][Full Text] [Related]
2. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation.
Lin K; Luo W; Yang N; Su L; Zhou H; Hu X; Wang Y; Khan ZA; Huang W; Wu G; Liang G
Int Immunopharmacol; 2022 Nov; 112():109218. PubMed ID: 36116148
[TBL] [Abstract][Full Text] [Related]
4. Ang II (Angiotensin II)-Induced FGFR1 (Fibroblast Growth Factor Receptor 1) Activation in Tubular Epithelial Cells Promotes Hypertensive Kidney Fibrosis and Injury.
Xu Z; Luo W; Chen L; Zhuang Z; Yang D; Qian J; Khan ZA; Guan X; Wang Y; Li X; Liang G
Hypertension; 2022 Sep; 79(9):2028-2041. PubMed ID: 35862110
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice.
Zheng C; Huang L; Luo W; Yu W; Hu X; Guan X; Cai Y; Zou C; Yin H; Xu Z; Liang G; Wang Y
Cell Death Dis; 2019 Nov; 10(11):848. PubMed ID: 31699972
[TBL] [Abstract][Full Text] [Related]
6. OTUD6A in tubular epithelial cells mediates angiotensin II-induced kidney injury by targeting STAT3.
Sun X; Chen S; Zhao Y; Wu T; Zhao Z; Luo W; Han J; Fang Z; Ye B; Cao G; Huang S; Liang G
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C400-C413. PubMed ID: 38105755
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease.
Pan J; Shi M; Guo F; Ma L; Fu P
Life Sci; 2021 Nov; 285():119946. PubMed ID: 34516993
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.
Matsui F; Babitz SK; Rhee A; Hile KL; Zhang H; Meldrum KK
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F25-F32. PubMed ID: 27760767
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling.
Han J; Ye S; Zou C; Chen T; Wang J; Li J; Jiang L; Xu J; Huang W; Wang Y; Liang G
Hypertension; 2018 Dec; 72(6):1301-1311. PubMed ID: 30571233
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension.
Johnson AW; Kinzenbaw DA; Modrick ML; Faraci FM
Hypertension; 2013 Feb; 61(2):437-42. PubMed ID: 23266544
[TBL] [Abstract][Full Text] [Related]
11. Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis.
Qian Y; Peng K; Qiu C; Skibba M; Huang Y; Xu Z; Zhang Y; Hu J; Liang D; Zou C; Wang Y; Liang G
J Pharmacol Exp Ther; 2016 Jan; 356(1):32-42. PubMed ID: 26514795
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice.
Zhang J; Xu Q; Ren F; Liu Y; Cai R; Yao Y; Zhou MS
Can J Physiol Pharmacol; 2021 Oct; 99(10):1000-1006. PubMed ID: 33852804
[TBL] [Abstract][Full Text] [Related]
14. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
Du Y; Zhang W; Liu S; Feng X; Gao F; Liu Q
Biochem Biophys Res Commun; 2018 Sep; 503(1):177-180. PubMed ID: 29885836
[TBL] [Abstract][Full Text] [Related]
15. Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4.
Milanesi S; Verzola D; Cappadona F; Bonino B; Murugavel A; Pontremoli R; Garibotto G; Viazzi F
J Cell Physiol; 2019 Jul; 234(7):10868-10876. PubMed ID: 30536556
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
[TBL] [Abstract][Full Text] [Related]
17. Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.
Wang Y; Fang Q; Jin Y; Liu Z; Zou C; Yu W; Li W; Shan X; Chen R; Khan Z; Liang G
Br J Pharmacol; 2019 Jul; 176(14):2642-2657. PubMed ID: 30959575
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3.
Qin Z; Bagley J; Sukhova G; Baur WE; Park HJ; Beasley D; Libby P; Zhang Y; Galper JB
J Mol Cell Cardiol; 2015 Oct; 87():160-70. PubMed ID: 26299839
[TBL] [Abstract][Full Text] [Related]
19. P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells.
Ni J; Shen Y; Wang Z; Shao DC; Liu J; Kong YL; Fu LJ; Zhou L; Xue H; Huang Y; Zhang W; Yu C; Lu LM
Acta Pharmacol Sin; 2014 Sep; 35(9):1157-66. PubMed ID: 25088002
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-22 exacerbates angiotensin II-induced hypertensive renal injury.
Wang W; Lu Y; Hu X; Li H; Li X; Xiao C; Meng T; Peng L; Gan L; Zhou Q; Xiao P; Tang R
Int Immunopharmacol; 2022 Aug; 109():108840. PubMed ID: 35567856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
